Description

This issue of Vital Signs, released on March 9, 2009, provides a strategic overview of the concept of stratified medicine. Additionally, a company spotlight is provided for PGxHealth, Inc., a division of Clinical Data Inc. specialized in biomarker discovery and development leading to the development of pharmacogenomics tests. Reimbursement and regulatory news from the FDA is also provided for the week of February 23, 2009.